| Regina Rae Paden, CNM | |
|
3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 | |
| (210) 539-9271 | |
| (210) 916-5102 |
| Full Name | Regina Rae Paden |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 3551 Roger Brooke Dr, Fort Sam Houston, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992768584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 81192 (Tennessee) | Secondary |
| 367A00000X | Advanced Practice Midwife | 127911 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Regina Rae Paden, CNM 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 Ph: (210) 539-9271 | Regina Rae Paden, CNM 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234-4504 Ph: (210) 539-9271 |
News Archive
Two proteins previously found to contribute to ALS, also known as Lou Gehrig's disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them.
New polysomnography parameters are better than conventional ones at describing how the severity of oxygen desaturation during sleep affects daytime alertness in patients with obstructive sleep apnea, according to a new study published in European Respiratory Journal.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Lawrence Livermore National Laboratory scientists have paired 3D-printed, living human brain vasculature with advanced computational flow simulations to better understand tumor cell attachment to blood vessels, the first step in secondary tumor formation during cancer metastasis.
Experts believe fear of needles may be preventing people from rolling up their sleeves for the H1N1 vaccination.
› Verified 5 days ago
Christy Nichole Jackson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-1661 | |
Mrs. Relisa Wilson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-4141 | |
Kathleen E. Hewitt, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Brooke Army Medical Center, Fort Sam Houston, TX 78234 Phone: 210-916-1598 |